Cargando…

Complete response in a patient with lung cancer suffering from three pembrolizumab‐induced immune‐related adverse events including retinal vasculitis

A 71‐year‐old man was diagnosed with squamous cell lung carcinoma with high expression of programmed cell death ligand 1 (PDL1) (cT4N1M1b stage IVA). He was treated with pembrolizumab, but 14 days later, he suffered from pembrolizumab‐related retinal vasculitis as an immune‐related adverse event (ir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mimura, Chihiro, Tachihara, Motoko, Kusuhara, Sentaro, Fukuoka, Hidenori, Nishimura, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938210/ https://www.ncbi.nlm.nih.gov/pubmed/33732464 http://dx.doi.org/10.1002/rcr2.730

Ejemplares similares

A case of panuveitis and retinal vasculitis associated with pembrolizumab therapy for metastatic lung cancer
por: Kim, Kyung Woo, et al.
Publicado: (2021)

Non‐parallel anti‐tumour effects of pembrolizumab: a case of cardial tamponade
por: Tachihara, Motoko, et al.
Publicado: (2019)

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
por: Nagano, Tatsuya, et al.
Publicado: (2018)

The Notable Appearance of Pulmonary Artery Intimal Sarcoma on Positron Emission Tomography (PET)/CT
por: Tachihara, Motoko, et al.
Publicado: (2017)

Possible Biomarkers for Cancer Immunotherapy
por: Otoshi, Takehiro, et al.
Publicado: (2019)

Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
por: Nagano, Tatsuya, et al.
Publicado: (2020)

The utility of bispectral index monitoring in flexible bronchoscopy: A single‐center, retrospective observational study
por: Yamada, Jun, et al.
Publicado: (2022)

Impaired Retinal Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma
por: Kimura, Masashi, et al.
Publicado: (2019)

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
por: Furukawa, Koichi, et al.
Publicado: (2020)

Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
por: Suraya, Ratoe, et al.
Publicado: (2022)

Effects of Elevated Intraocular Pressure on Retinal Ganglion Cell Density and Expression and Interaction of Retinal Aquaporin 9 and Monocarboxylate Transporters
por: Murai, Yusuke, et al.
Publicado: (2023)

Angiographic findings before and after the onset of brolucizumab-associated retinal vascular occlusion and intraocular inflammation
por: Kusuhara, Sentaro, et al.
Publicado: (2022)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
por: Oishi, Hideo, et al.
Publicado: (2020)

Immune-related adverse event profile of combination treatment of PD-(L)1 checkpoint inhibitors and bevacizumab in non-small cell lung cancer patients: data from the FDA adverse event reporting system
por: Bai, Shuai, et al.
Publicado: (2021)

Yield of tumor samples with a large guide-sheath in endobronchial ultrasound transbronchial biopsy for non-small cell lung cancer: A prospective study
por: Katsurada, Naoko, et al.
Publicado: (2021)

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
por: Sato, Hiroki, et al.
Publicado: (2020)

Pembrolizumab‐caused polyradiculoneuropathy as an immune‐related adverse event
por: Kurashige, Takashi, et al.
Publicado: (2021)

Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
por: Miwa, Nanako, et al.
Publicado: (2020)

TAPO in first‐line osimertinib therapy and continuation of osimertinib
por: Mimura, Chihiro, et al.
Publicado: (2022)

Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
por: Lima, Gian, et al.
Publicado: (2019)

Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody
por: Urai, Shin, et al.
Publicado: (2023)

Adverse events in allergy sufferers wearing contact lenses
por: Urgacz, Agnieszka, et al.
Publicado: (2015)

Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection
por: Kusuhara, Sentaro, et al.
Publicado: (2020)

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)
por: Tachihara, Motoko, et al.
Publicado: (2018)

Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy
por: Katsurada, Masahiro, et al.
Publicado: (2022)

Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
por: de Filette, Jeroen, et al.
Publicado: (2016)

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients
por: Schaefer, Anne, et al.
Publicado: (2020)

Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer
por: Mimura, Kaito, et al.
Publicado: (2022)

Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer
por: Tachihara, Motoko, et al.
Publicado: (2020)

Diagnostic yield and the number of tumor cells of ultrathin bronchoscopy for peripheral lung lesions: A comparison with thin bronchoscopy
por: Yatani, Atsuhiko, et al.
Publicado: (2023)

Differential Diagnosis of Retinal Vasculitis
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2009)

Macular changes in retinal vasculitis
por: Saurabh, Kumar, et al.
Publicado: (2018)

Retinal Vasculitis Secondary to Durvalumab
por: R. Andrade, Antonio, et al.
Publicado: (2020)

Cystotomy with or without fibrinogen clot removal for refractory cystoid macular edema secondary to branch retinal vein occlusion
por: Yamada, Hiroko, et al.
Publicado: (2021)

Aqp9 Gene Deletion Enhances Retinal Ganglion Cell (RGC) Death and Dysfunction Induced by Optic Nerve Crush: Evidence that Aquaporin 9 Acts as an Astrocyte-to-Neuron Lactate Shuttle in Concert with Monocarboxylate Transporters To Support RGC Function and Survival
por: Mori, Sotaro, et al.
Publicado: (2020)

An unusual adverse event of azathioprine: Cutaneous small vessel vasculitis
por: Hanai, Shunichiro, et al.
Publicado: (2021)

A Case of Nonsmall-Cell Lung Cancer with Anaphylaxis after 41 Courses of Pembrolizumab along with Adrenal Insufficiency as an Immune-Related Adverse Event
por: Nakamura, Tomoaki, et al.
Publicado: (2022)

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer
por: Marhold, Maximilian, et al.
Publicado: (2023)

Secondary dengue retinitis with associated occlusive retinal vasculitis
por: Koundanya, Vikram Vinayak, et al.
Publicado: (2019)

Randomized cross-over trial of demand oxygen delivery system
por: Nagano, Tatsuya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tln8vd5rsqrh8j5k3b9e7ntu85